Related Experiment Video
Updated: Jan 29, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling
Saad A Khan1, Bo Ci2, Yang Xie2
1Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Introduction:
Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Those ATC with genomic alterations (GAs) in TSC2, ALK, and BRAF may respond to targeted therapies.
Methods:
Comprehensive genomic profiling on 90 ATC specimens identified base substitutions, short insertions and deletions, amplifications, copy number alterations, and genomic rearrangements in up to 315 cancer-related genes and 28 genes commonly rearranged in cancer.
Results:
Median patient age was 65 (range, 33-86) years, 50 patients were male. There was a mean of 4.2 GA per case, range 1-11. The most common GA were TP53 (66%), BRAF (34%), TERT (32%), CDKN2A (32%), and NRAS (26%). BRAF V600E and NRAS/HRAS/KRAS alteration were mutually exclusive. BRAF, CDKN2A, PIK3CA, and JAK2 were more frequent in patients >70 years of age; while myc, PTEN, and NRAS were more common in those ≤50 years.
Conclusion:
ATC shows many GA with potential therapeutic significance and suggesting different molecular pathways can lead to ATC.
Insights
Anaplastic thyroid cancer (ATC) exhibits numerous genomic alterations (GAs) with therapeutic potential. Identifying these GAs, such as in BRAF, is crucial for developing targeted therapies for this aggressive cancer.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Anaplastic thyroid cancer (ATC) is an aggressive malignancy.
- Specific genomic alterations (GAs) in genes like TSC2, ALK, and BRAF may indicate susceptibility to targeted treatments.
Purpose of the Study:
- To comprehensively profile the genomic landscape of anaplastic thyroid cancer.
- To identify actionable genomic alterations for potential targeted therapy.
Main Methods:
- Conducted comprehensive genomic profiling on 90 ATC specimens.
- Analyzed base substitutions, insertions/deletions, amplifications, copy number alterations, and genomic rearrangements across hundreds of cancer-related genes.
Main Results:
- Identified a mean of 4.2 genomic alterations per case, with TP53 (66%), BRAF (34%), TERT (32%), CDKN2A (32%), and NRAS (26%) being most frequent.
- Observed mutually exclusive alterations between BRAF V600E and NRAS/HRAS/KRAS.
- Found age-related differences in GA frequency, with certain alterations more common in older or younger patient groups.
Conclusions:
- Anaplastic thyroid cancer is characterized by a high number of genomic alterations.
- These GAs hold significant therapeutic implications and suggest diverse molecular pathways driving ATC development.
Related Concept Videos
Mutations
Genomics
Other Unique Bacteria
Second Uniqueness Theorem
In contrast, consider that the electric field is non-unique and apply Gauss's law in divergence form in the region between the conductors and the integral form to the surface...
Cancers Originate from Somatic Mutations in a Single Cell
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

